** Shares of Fisher & Paykel Healthcare Corporation FPH.NZ fall 4.8% to NZ$33.4
** Stock down as much as 7.1%, hits lowest level since March 25
** The medical equipment maker says costs would likely increase for FY26 due to the new U.S. tariffs
** The U.S. tariffs may add to co's timeframe to achieve its gross margin target, co adds
** However, co doesn't anticipate material impact from U.S. tariffs on its net profit after tax for FY2025
** Stock down 8.6% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。